Gomez-Bougie, Patricia <br/><br/>
The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells.  [electronic resource] 

 -  European journal of immunology  Nov 2004 
 - 3156-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-2980 
<br/><br/><label>Standard No.: </label>10.1002/eji.200424981  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--physiology<br/>Apoptosis Regulatory Proteins<br/>Bcl-2-Like Protein 11<br/>Carrier Proteins--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Cell Survival--physiology<br/>Cycloheximide--pharmacology<br/>Dactinomycin--pharmacology<br/>Humans<br/>Interleukin-6--immunology<br/>Janus Kinase 2<br/>Membrane Proteins--antagonists & inhibitors<br/>Multiple Myeloma--immunology<br/>Myeloid Cell Leukemia Sequence 1 Protein<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Protein Isoforms<br/>Protein Synthesis Inhibitors--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Proto-Oncogene Proteins--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors<br/>Transcription, Genetic--immunology<br/>Tyrphostins--pharmacology